Angeline S. Andrew, Ph.D. - Publications

Affiliations: 
2001 Dartmouth College, Hanover, NH, United States 
Area:
Toxicology

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Li J, Malley JD, Andrew AS, Karagas MR, Moore JH. Detecting gene-gene interactions using a permutation-based random forest method. Biodata Mining. 9: 14. PMID 27053949 DOI: 10.1186/s13040-016-0093-5  1
2015 Hu T, Andrew AS, Karagas MR, Moore JH. Functional dyadicity and heterophilicity of gene-gene interactions in statistical epistasis networks. Biodata Mining. 8: 43. PMID 26697115 DOI: 10.1186/s13040-015-0062-4  1
2015 Hu S, Danilov AV, Godek K, Orr B, Tafe LJ, Rodriguez-Canales J, Behrens C, Mino B, Moran CA, Memoli VA, Mustachio LM, Galimberti F, Ravi S, DeCastro A, Lu Y, ... ... Andrew AS, et al. CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110. Cancer Research. 75: 2029-38. PMID 25808870 DOI: 10.1158/0008-5472.CAN-14-1494  1
2015 Frost HR, Andrew AS, Karagas MR, Moore JH. A screening-testing approach for detecting gene-environment interactions using sequential penalized and unpenalized multiple logistic regression. Pacific Symposium On Biocomputing. Pacific Symposium On Biocomputing. 183-94. PMID 25592580  1
2015 Andrew AS, Gui J, Hu T, Wyszynski A, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Ekstrom RM, Li Z, Zens MS, Borsuk M, Moore JH, Karagas MR. Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study. Bju International. 115: 238-47. PMID 24666523 DOI: 10.1111/bju.12641  1
2014 Andrew AS, Marsit CJ, Schned AR, Seigne JD, Kelsey KT, Moore JH, Perreard L, Karagas MR, Sempere LF. Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence. International Journal of Cancer. Journal International Du Cancer. PMID 25556547 DOI: 10.1002/ijc.29413  1
2014 Hu T, Pan Q, Andrew AS, Langer JM, Cole MD, Tomlinson CR, Karagas MR, Moore JH. Functional genomics annotation of a statistical epistasis network associated with bladder cancer susceptibility. Biodata Mining. 7: 5. PMID 24725556 DOI: 10.1186/1756-0381-7-5  1
2014 Kim CH, Lee YC, Hung RJ, McNallan SR, Cote ML, Lim WY, Chang SC, Kim JH, Ugolini D, Chen Y, Liloglou T, Andrew AS, Onega T, Duell EJ, Field JK, et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). International Journal of Cancer. Journal International Du Cancer. 135: 1918-30. PMID 24615328 DOI: 10.1002/ijc.28835  1
2014 Pan Q, Hu T, Malley JD, Andrew AS, Karagas MR, Moore JH. A system-level pathway-phenotype association analysis using synthetic feature random forest. Genetic Epidemiology. 38: 209-19. PMID 24535726 DOI: 10.1002/gepi.21794  1
2014 Wyszynski A, Tanyos SA, Rees JR, Marsit CJ, Kelsey KT, Schned AR, Pendleton EM, Celaya MO, Zens MS, Karagas MR, Andrew AS. Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer. 120: 408-14. PMID 24122218 DOI: 10.1002/cncr.28394  1
2014 Koestler DC, Li J, Baron JA, Tsongalis GJ, Butterly LF, Goodrich M, Lesseur C, Karagas MR, Marsit CJ, Moore JH, Andrew AS, Srivastava A. Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 27: 145-55. PMID 23868178 DOI: 10.1038/modpathol.2013.104  1
2013 Pesatori AC, Carugno M, Consonni D, Hung RJ, Papadoupolos A, Landi MT, Brenner H, Müller H, Harris CC, Duell EJ, Andrew AS, McLaughlin JR, Schwartz AG, Wenzlaff AS, Stucker I. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). British Journal of Cancer. 109: 1954-64. PMID 24002594 DOI: 10.1038/bjc.2013.506  1
2013 Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, et al. Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy. International Journal of Cancer. 133: 2004-9. PMID 23553206 DOI: 10.1002/ijc.28186  1
2013 Urbanowicz RJ, Andrew AS, Karagas MR, Moore JH. Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: a learning classifier system approach. Journal of the American Medical Informatics Association : Jamia. 20: 603-12. PMID 23444013 DOI: 10.1136/amiajnl-2012-001574  1
2013 Hu T, Andrew AS, Karagas MR, Moore JH. Statistical epistasis networks reduce the computational complexity of searching three-locus genetic models. Pacific Symposium On Biocomputing. Pacific Symposium On Biocomputing. 397-408. PMID 23424144  1
2013 Pan Q, Hu T, Malley JD, Andrew AS, Karagas MR, Moore JH. Supervising random forest using attribute interaction networks Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 7833: 104-116. DOI: 10.1007/978-3-642-37189-9_10  1
2012 Sloan CD, Andrew AS, Gruber JF, Mwenda KM, Moore JH, Onega T, Karagas MR, Shi X, Duell EJ. Indoor and Outdoor Air Pollution and Lung Cancer in New Hampshire and Vermont. Toxicological and Environmental Chemistry. 94. PMID 24273369 DOI: 10.1080/02772248.2012.659930  1
2012 Andrew AS, Hu T, Gu J, Gui J, Ye Y, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Mason RA, Morlock EV, Zens MS, Li Z, Moore JH, et al. HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. Plos One. 7: e51301. PMID 23284679 DOI: 10.1371/journal.pone.0051301  1
2012 Brenner DR, Boffetta P, Duell EJ, Bickeböller H, Rosenberger A, McCormack V, Muscat JE, Yang P, Wichmann HE, Brueske-Hohlfeld I, Schwartz AG, Cote ML, Tjønneland A, Friis S, Le Marchand L, ... ... Andrew AS, et al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. American Journal of Epidemiology. 176: 573-85. PMID 22986146 DOI: 10.1093/aje/kws151  1
2012 Galimberti F, Busch AM, Chinyengetere F, Ma T, Sekula D, Memoli VA, Dragnev KH, Liu F, Johnson KC, Guo Y, Freemantle SJ, Andrew AS, Greninger P, Robbins DJ, Settleman J, et al. Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations. International Journal of Oncology. 41: 1751-61. PMID 22923130 DOI: 10.3892/ijo.2012.1599  1
2012 Ma J, Xiao F, Xiong M, Andrew AS, Brenner H, Duell EJ, Haugen A, Hoggart C, Hung RJ, Lazarus P, Liu C, Matsuo K, Mayordomo JI, Schwartz AG, Staratschek-Jox A, et al. Natural and orthogonal interaction framework for modeling gene-environment interactions with application to lung cancer. Human Heredity. 73: 185-94. PMID 22889990 DOI: 10.1159/000339906  1
2012 Guo Y, Chinyengetere F, Dolinko AV, Lopez-Aguiar A, Lu Y, Galimberti F, Ma T, Feng Q, Sekula D, Freemantle SJ, Andrew AS, Memoli V, Dmitrovsky E. Evidence for the ubiquitin protease UBP43 as an antineoplastic target. Molecular Cancer Therapeutics. 11: 1968-77. PMID 22752428 DOI: 10.1158/1535-7163.MCT-12-0248  1
2012 Coté ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR, Muscat JE, Rennert G, Aben KK, Andrew AS, Bencko V, Bickeböller H, Boffetta P, Brennan P, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. European Journal of Cancer (Oxford, England : 1990). 48: 1957-68. PMID 22436981 DOI: 10.1016/j.ejca.2012.01.038  1
2012 Lesseur C, Gilbert-Diamond D, Andrew AS, Ekstrom RM, Li Z, Kelsey KT, Marsit CJ, Karagas MR. A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire. Toxicology Letters. 210: 100-6. PMID 22306368 DOI: 10.1016/j.toxlet.2012.01.015  1
2012 Rosenberger A, Bickeböller H, McCormack V, Brenner DR, Duell EJ, Tjønneland A, Friis S, Muscat JE, Yang P, Wichmann HE, Heinrich J, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, ... ... Andrew AS, et al. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis. 33: 587-97. PMID 22198214 DOI: 10.1093/carcin/bgr307  1
2012 Karagas MR, Andrew AS, Nelson HH, Li Z, Punshon T, Schned A, Marsit CJ, Morris JS, Moore JH, Tyler AL, Gilbert-Diamond D, Guerinot ML, Kelsey KT. SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer. Human Genetics. 131: 453-61. PMID 21947419 DOI: 10.1007/s00439-011-1090-x  1
2011 McCormack VA, Hung RJ, Brenner DR, Bickeböller H, Rosenberger A, Muscat JE, Lazarus P, Tjønneland A, Friis S, Christiani DC, Chun EM, Le Marchand L, Rennert G, Rennert HS, Andrew AS, et al. Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). Cancer Causes & Control : Ccc. 22: 1709-20. PMID 21987079 DOI: 10.1007/s10552-011-9847-z  1
2011 Hu T, Sinnott-Armstrong NA, Kiralis JW, Andrew AS, Karagas MR, Moore JH. Characterizing genetic interactions in human disease association studies using statistical epistasis networks. Bmc Bioinformatics. 12: 364. PMID 21910885 DOI: 10.1186/1471-2105-12-364  1
2011 Gui J, Andrew AS, Andrews P, Nelson HM, Kelsey KT, Karagas MR, Moore JH. A robust multifactor dimensionality reduction method for detecting gene-gene interactions with application to the genetic analysis of bladder cancer susceptibility. Annals of Human Genetics. 75: 20-8. PMID 21091664 DOI: 10.1111/j.1469-1809.2010.00624.x  1
2011 Gui J, Moore JH, Kelsey KT, Marsit CJ, Karagas MR, Andrew AS. A novel survival multifactor dimensionality reduction method for detecting gene-gene interactions with application to bladder cancer prognosis. Human Genetics. 129: 101-10. PMID 20981448 DOI: 10.1007/s00439-010-0905-5  1
2010 Gui J, Andrew AS, Andrews P, Nelson HM, Kelsey KT, Karagas MR, Moore JH. A simple and computationally efficient sampling approach to covariate adjustment for multifactor dimensionality reduction analysis of epistasis. Human Heredity. 70: 219-25. PMID 20924193 DOI: 10.1159/000319175  1
2010 Hosgood HD, Boffetta P, Greenland S, Lee YC, McLaughlin J, Seow A, Duell EJ, Andrew AS, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabiánová E, Mates D, Bencko V, et al. In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium. Environmental Health Perspectives. 118: 1743-7. PMID 20846923 DOI: 10.1289/ehp.1002217  1
2010 Marsit CJ, Houseman EA, Christensen BC, Gagne L, Wrensch MR, Nelson HH, Wiemels J, Zheng S, Wiencke JK, Andrew AS, Schned AR, Karagas MR, Kelsey KT. Identification of methylated genes associated with aggressive bladder cancer. Plos One. 5: e12334. PMID 20808801 DOI: 10.1371/journal.pone.0012334  1
2010 Truong T, Hung RJ, Amos CI, Wu X, Bickeböller H, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch A, Dienemann H, Kaaks R, Yang P, Jiang R, Wiencke JK, ... ... Andrew AS, et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. Journal of the National Cancer Institute. 102: 959-71. PMID 20548021 DOI: 10.1093/jnci/djq178  1
2010 Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. The Journal of Clinical Investigation. 120: 1298-309. PMID 20237410 DOI: 10.1172/JCI39566  1
2010 Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, Karagas MR, Marsit CJ. Implications of LINE1 methylation for bladder cancer risk in women. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1682-9. PMID 20179218 DOI: 10.1158/1078-0432.CCR-09-2983  1
2010 Truong T, Sauter W, McKay JD, Hosgood HD, Gallagher C, Amos CI, Spitz M, Muscat J, Lazarus P, Illig T, Wichmann HE, Bickeböller H, Risch A, Dienemann H, Zhang ZF, ... ... Andrew AS, et al. International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. Carcinogenesis. 31: 625-33. PMID 20106900 DOI: 10.1093/carcin/bgq001  1
2010 Greene CS, Himmelstein DS, Nelson HH, Kelsey KT, Williams SM, Andrew AS, Karagas MR, Moore JH. Enabling personal genomics with an explicit test of epistasis. Pacific Symposium On Biocomputing. Pacific Symposium On Biocomputing. 327-36. PMID 19908385  1
2010 Kwong RC, Karagas MR, Kelsey KT, Mason RA, Tanyos SA, Schned AR, Marsit CJ, Andrew AS. Arsenic exposure predicts bladder cancer survival in a US population. World Journal of Urology. 28: 487-92. PMID 19834714 DOI: 10.1007/s00345-009-0477-y  1
2009 Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ. Lung cancer in a U.S. population with low to moderate arsenic exposure. Environmental Health Perspectives. 117: 1718-23. PMID 20049123 DOI: 10.1289/ehp.0900566  1
2009 Baris D, Karagas MR, Verrill C, Johnson A, Andrew AS, Marsit CJ, Schwenn M, Colt JS, Cherala S, Samanic C, Waddell R, Cantor KP, Schned A, Rothman N, Lubin J, et al. A case-control study of smoking and bladder cancer risk: emergent patterns over time. Journal of the National Cancer Institute. 101: 1553-61. PMID 19917915 DOI: 10.1093/jnci/djp361  1
2009 Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, Yuan JM, Matullo G, Fletcher T, Benhamou S, Taylor JA, Placidi D, Zhang ZF, Steineck G, Rothman N, Kogevinas M, ... ... Andrew AS, et al. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Research. 69: 6857-64. PMID 19706757 DOI: 10.1158/0008-5472.CAN-09-1091  1
2009 Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang ZF, Kiltie AE, Bishop DT, et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nature Genetics. 41: 991-5. PMID 19648920 DOI: 10.1038/ng.421  1
2009 Andrew AS, Mason RA, Kelsey KT, Schned AR, Marsit CJ, Nelson HH, Karagas MR. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicology Letters. 187: 10-4. PMID 19429237 DOI: 10.1016/j.toxlet.2009.01.013  1
2009 Mason RA, Morlock EV, Karagas MR, Kelsey KT, Marsit CJ, Schned AR, Andrew AS. EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Carcinogenesis. 30: 1155-60. PMID 19372140 DOI: 10.1093/carcin/bgp077  1
2009 Andrew AS, Gui J, Sanderson AC, Mason RA, Morlock EV, Schned AR, Kelsey KT, Marsit CJ, Moore JH, Karagas MR. Bladder cancer SNP panel predicts susceptibility and survival. Human Genetics. 125: 527-39. PMID 19252927 DOI: 10.1007/s00439-009-0645-6  1
2009 Andrew AS, Mason RA, Memoli V, Duell EJ. Arsenic activates EGFR pathway signaling in the lung. Toxicological Sciences : An Official Journal of the Society of Toxicology. 109: 350-7. PMID 19168569 DOI: 10.1093/toxsci/kfp015  1
2009 Wallace K, Kelsey KT, Schned A, Morris JS, Andrew AS, Karagas MR. Selenium and risk of bladder cancer: a population-based case-control study. Cancer Prevention Research (Philadelphia, Pa.). 2: 70-3. PMID 19139020 DOI: 10.1158/1940-6207.CAPR-08-0046  1
2009 Sloan CD, Duell EJ, Shi X, Irwin R, Andrew AS, Williams SM, Moore JH. Ecogeographic genetic epidemiology. Genetic Epidemiology. 33: 281-9. PMID 19025788 DOI: 10.1002/gepi.20386  1
2009 Pattin KA, White BC, Barney N, Gui J, Nelson HH, Kelsey KT, Andrew AS, Karagas MR, Moore JH. A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genetic Epidemiology. 33: 87-94. PMID 18671250 DOI: 10.1002/gepi.20360  1
2008 Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, Zienolddiny S, Benhamou S, Bouchardy C, Lan Q, Spitz MR, Wichmann HE, LeMarchand L, Vineis P, Matullo G, Kiyohara C, ... ... Andrew AS, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3081-9. PMID 18990748 DOI: 10.1158/1055-9965.EPI-08-0411  1
2008 Hays AM, Lantz RC, Rodgers LS, Sollome JJ, Vaillancourt RR, Andrew AS, Hamilton JW, Camenisch TD. Arsenic-induced decreases in the vascular matrix. Toxicologic Pathology. 36: 805-17. PMID 18812580 DOI: 10.1177/0192623308323919  1
2008 Schned AR, Andrew AS, Marsit CJ, Kelsey KT, Zens MS, Karagas MR. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scandinavian Journal of Urology and Nephrology. 42: 237-42. PMID 18432530 DOI: 10.1080/00365590801948166  1
2008 Andrew AS, Jewell DA, Mason RA, Whitfield ML, Moore JH, Karagas MR. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environmental Health Perspectives. 116: 524-31. PMID 18414638 DOI: 10.1289/ehp.10861  1
2008 Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, Vineis P, Matullo G. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Human Heredity. 65: 105-18. PMID 17898541 DOI: 10.1159/000108942  1
2008 Moore JH, Karagas MR, Andrew AS. Analysis of Complex Datasets Molecular Epidemiology of Chronic Diseases. 207-222. DOI: 10.1002/9780470725726.ch16  1
2007 Schned AR, Andrew AS, Marsit CJ, Zens MS, Kelsey KT, Karagas MR. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems. The Journal of Urology. 178: 1196-200; discussion. PMID 17698105 DOI: 10.1016/j.juro.2007.05.126  1
2007 Fortuny J, Kogevinas M, Zens MS, Schned A, Andrew AS, Heaney J, Kelsey KT, Karagas MR. Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. Bmc Urology. 7: 13. PMID 17692123 DOI: 10.1186/1471-2490-7-13  1
2007 Andrew AS, Bernardo V, Warnke LA, Davey JC, Hampton T, Mason RA, Thorpe JE, Ihnat MA, Hamilton JW. Exposure to arsenic at levels found inU.S. drinking water modifies expression in the mouse lung. Toxicological Sciences : An Official Journal of the Society of Toxicology. 100: 75-87. PMID 17682005 DOI: 10.1093/toxsci/kfm200  1
2007 Karagas MR, Zens MS, Nelson HH, Mabuchi K, Perry AE, Stukel TA, Mott LA, Andrew AS, Applebaum KM, Linet M. Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. American Journal of Epidemiology. 165: 719-26. PMID 17204514 DOI: 10.1093/aje/kwk055  1
2006 Andrew AS, Burgess JL, Meza MM, Demidenko E, Waugh MG, Hamilton JW, Karagas MR. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environmental Health Perspectives. 114: 1193-8. PMID 16882524 DOI: 10.1289/ehp.9008  1
2006 Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, Tosteson TD, Schned AR, Karagas MR. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis. 27: 1030-7. PMID 16311243 DOI: 10.1093/carcin/bgi284  1
2005 Karagas MR, Park S, Nelson HH, Andrew AS, Mott L, Schned A, Kelsey KT. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. International Journal of Hygiene and Environmental Health. 208: 321-7. PMID 16217917 DOI: 10.1016/j.ijheh.2005.04.005  1
2004 Andrew AS, Schned AR, Heaney JA, Karagas MR. Bladder cancer risk and personal hair dye use. International Journal of Cancer. 109: 581-6. PMID 14991581 DOI: 10.1002/ijc.11729  1
2003 Andrew AS, Warren AJ, Barchowsky A, Temple KA, Klei L, Soucy NV, O'Hara KA, Hamilton JW. Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environmental Health Perspectives. 111: 825-35. PMID 12760830  1
2003 Andrew AS, Karagas MR, Hamilton JW. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. International Journal of Cancer. Journal International Du Cancer. 104: 263-8. PMID 12569548 DOI: 10.1002/ijc.10968  1
2002 Barchowsky A, Soucy NV, O'Hara KA, Hwa J, Noreault TL, Andrew AS. A novel pathway for nickel-induced interleukin-8 expression. The Journal of Biological Chemistry. 277: 24225-31. PMID 11978798 DOI: 10.1074/jbc.M202941200  1
2001 Andrew AS, Klei LR, Barchowsky A. AP-1-dependent induction of plasminogen activator inhibitor-1 by nickel does not require reactive oxygen. American Journal of Physiology. Lung Cellular and Molecular Physiology. 281: L616-23. PMID 11504688  1
2001 Andrew AS, Klei LR, Barchowsky A. Nickel requires hypoxia-inducible factor-1 alpha, not redox signaling, to induce plasminogen activator inhibitor-1. American Journal of Physiology. Lung Cellular and Molecular Physiology. 281: L607-15. PMID 11504687  1
1999 Jacobs JM, Nichols CE, Andrew AS, Marek DE, Wood SG, Sinclair PR, Wrighton SA, Kostrubsky VE, Sinclair JF. Effect of arsenite on induction of CYP1A, CYP2B, and CYP3A in primary cultures of rat hepatocytes Toxicology and Applied Pharmacology. 157: 51-59. PMID 10329507 DOI: 10.1006/taap.1999.8659  1
Show low-probability matches.